4//SEC Filing
McCamish Mark Anthony 4
Accession 0001104659-23-091957
CIK 0001012477other
Filed
Aug 14, 8:00 PM ET
Accepted
Aug 15, 4:13 PM ET
Size
5.8 KB
Accession
0001104659-23-091957
Insider Transaction Report
Form 4
McCamish Mark Anthony
Director
Transactions
- Sale
ADSs
2023-08-11$14.93/sh−28,975$432,614→ 142,025 total(indirect: By LLC)
Footnotes (3)
- [F1]The Issuer's "ADSs" are American Depositary Shares, with each ADS representing one ordinary share, nominal value $0.01 per share, of the Issuer; ADSs may be represented by American Depositary Receipts.
- [F2]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $14.75 to $15.20, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.
- [F3]Shares held by Matthew 5 LLC. The Mark & Barbara McCamish Family Trust is the sole owner of Matthew 5 LLC, and the Reporting Person serves as its manager.
Documents
Issuer
AVADEL PHARMACEUTICALS PLC
CIK 0001012477
Entity typeother
Related Parties
1- filerCIK 0001390798
Filing Metadata
- Form type
- 4
- Filed
- Aug 14, 8:00 PM ET
- Accepted
- Aug 15, 4:13 PM ET
- Size
- 5.8 KB